Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SimplyCare Bio is a South Korean green-bio and animal-health company developing functional food and livestock-health products based on bio-conversion, fatty-acid water-solubilization, and innate-immunity activation technologies. The company appears to focus on improving livestock resilience and productivity while also commercializing premium nutrition products enriched with omega-3 fatty acids. Its portfolio and website materials highlight branded products spanning eggs, pork, milk, chicken, and tomato-based offerings marketed under the Ogg/OGReat family. Rather than operating as a traditional human therapeutics biotech with a clinical pipeline, SimplyCare Bio is best characterized as a commercialization-stage care-food and agri-bio company working at the intersection of animal health, functional ingredients, and sustainable food production. The business is active and privately held, with operations in South Korea and reported seed-stage venture backing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SimplyCare.